Form 4 Filing for John Patience

This filing details transactions made by John Patience, Chairman of BIODESIX INC, on June 30, 2026. The transactions involved the disposal of 1361 Restricted Stock Units (RSUs), with each RSU representing a contingent right to one share of the Issuer's common stock. These RSUs are subject to vesting in installments through December 31, 2026, contingent upon continued service. The filing also reports non-derivative transactions, including the acquisition of 1361 shares of common stock. Following these transactions, John Patience's holdings include 107,664 shares held indirectly through Patience Enterprises LP, 241,480 shares through the John Patience Living Trust, and 2,649 shares held by his spouse. The total post-transaction shares reported for direct ownership of common stock are 25,383.